Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by Tson99on May 19, 2009 9:00pm
405 Views
Post# 16002397

RE: So Where are We? Good Question, he asked?

RE: So Where are We? Good Question, he asked?
To Ignore, click the little arrow under the picture of the poster, and select ignore.

My guess is they are not going bankrupt, but will continue the slow slide down to the .30 cent level until there is some kind of positive announcement is made.

By the way I emailed Jennifer back on May 11th

Hello Jennifer,
 
As a Bioniche stock holder (60,700 shares) the last announcement has made me a bit uneasy to say the least, are there any additional updates or information you can provide that would help to put my mind at ease.

Here is the response, I think it's the same response everone has received, although I don't remember her using the work quickly before. When I received this email, I responded back asking her what her definition of quickly was and to date I have not received a response.

Hello Mr. XXX,

 

We have been working diligently to improve our financial position and are making good progress in that regard.

 

Unfortunately, we suffered a setback when we were in very advanced negotiations with a partner for our bladder cancer technology and learned that the potential partner was changing its internal strategic direction. We need a partner that will support the development of Urocidin with a commitment to its successful commercialization. We have several potential partners actively pursuing the opportunity at this time and we are aiming to conclude a transaction quickly.

 

The Company has also been considering potential monetization of other corporate assets. There has been significant interest on the part of potential investors and some promising leads are being explored.

 

Internal cost cutting measures are also taking place. These measures will allow us to stretch our financial resources further to accomplish the above objectives.

 

Sincerely,


Jennifer

Jennifer Shea

Vice-President of Communications,

Investor & Government Relations

Bioniche Life Sciences Inc.

P.O. Box 1570, 231 Dundas St. E.

Belleville, Ontario

K8N 5J2

phone: (613) 966-8058 ext. 1250

cell: (613) 391-2097

fax: (613) 966-4177

Jennifer.Shea@Bioniche.com

Bullboard Posts